Join on WhatsApp 
Join on Telegram Rabat – Mohamed El Guerrouj, Director General of the National Agency for the Regulation of Cannabis-Related Activities (ANRAC), emphasized that Morocco has reinforced its position in the regulated therapeutic cannabis sector.
He made his remarks on Saturday during the first scientific day on the therapeutic use of cannabis. ANRAC organized the event in partnership with the Moroccan Society of Medical Sciences (SMSM).
El Guerrouj said more than 140 cannabis-based products have been manufactured by the Moroccan industry and officially registered with the Moroccan Agency for Medicines and Health Products (AMMPS).
The products are also available in over 600 authorized points of sale.
SMSM President Moualy Said Afif said Morocco’s experience is considered one of the most prominent models in the field, adding that the first scientific day supports efforts committed to contributing to the development of action plans aimed at boosting the use of cannabis for health purposes.
In April, El Guerrouj said total production of dried cannabis reached 19,576 quintals in 2025, up from 18,810 quintals in 2024. This increase reflects what he described as a “qualitative leap” in the sector’s development.
The agency issued 4,147 new licenses last year, bringing the total number of active permits to 5,765 for the 2025 season. Most of these licenses, 5,492, were for cultivation, benefiting 5,318 farmers. The remaining 273 licenses covered processing, marketing, export, seed import, and transport activities, involving 183 operators.
In March 2021, Morocco adopted bill 13-21, which made Morocco one of the first African countries to permit the use of cannabis for medical and therapeutic purposes.
Through Law 13.21, Morocco aims to improve farmers’ income and create stable job opportunities by forcing them to opt for legal cannabis production.
